Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotensin receptor type 2 (NTSR2) is a G protein-coupled receptor that binds the neuropeptide neurotensin. It is predominantly expressed in the brain, particularly in astrocytes, and plays roles in neuromodulation, analgesia, and modulation of fear memory. NTSR2 represents a potential therapeutic target for pain management, with selective agonists showing promise for potent analgesia without the side effects associated with broader neurotensin receptor activation. There is also research into the potential role of NTSR2 in cancer cell survival.
Agonist or antagonist binding to NTSR2, modulating downstream signaling pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotensin Receptor Type 2 (None).